Clinical trial
A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer
NCT03655353
Study timeline
Study start (actual)2018-08-22Date precision: day
Registry last updated2021-09-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HER2-positive Breast Cancerunresolved
Interventions
ABY-PETDIAGNOSTIC_TEST
Sponsors & collaborators
Henrik Lindmanlead sponsor
Roche Pharma AGcollaborator
Swedish Cancer Societycollaborator
Affibodycollaborator
Swedish Breast Cancer Groupcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03655353 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.